Method and medicament for inhibiting the expression of a defined gene

Details for Australian Patent Application No. 2005201044 (hide)

Owner Alnylam Europe AG

Inventors Limmer, Stephan; Kreutzer, Roland

Agent Griffith Hack

Pub. Number AU-B-2005201044

Parent 778474

Filing date 9 March 2005

Wipo publication date 7 April 2005

Acceptance publication date 29 May 2008

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 9/127 (2006.01) Medicinal preparations characterised by special physical form - Liposomes

A61K 31/70 (2006.01) - Carbohydrates

A61K 31/713 (2006.01) - Double-stranded nucleic acids or oligonucleotides

A61K 35/76 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

24 March 2005 Complete Application Filed

7 April 2005 Application Open to Public Inspection

  Published as AU-B-2005201044

29 May 2008 Assignment before Grant

  Roland Kreutzer; Stephan Limmer The application has been assigned to Alnylam Europe AG

29 May 2008 Application Accepted

  Published as AU-B-2005201044

18 September 2008 Opposition Lodged

  Sirna Therapeutics, Inc. has lodged an opposition against Alnylam Europe AG.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005201045-Combination therapy of angiotensin converting enzyme inhibitor and epoxysteroidal aldosterone antagonist for treatment of cardiovascular disease

2005201043-Personal body grounding system